Dicot Pharma AB (STO:DICOT)
Sweden · Delayed Price · Currency is SEK 0.2400
-0.0068 (-2.76%)
At close: Oct 14, 2026
Dicot Pharma AB Market Cap
Dicot Pharma AB has a market cap or net worth of 832.49 million as of October 14, 2026. It is the 26,597th most valuable company in the world and the 329th biggest in Sweden. Its market cap has decreased by 59.38% in one year.
Market Cap
832.49M
Enterprise Value
584.09M
Revenue
n/a
Global Rank
Country Rank
#329 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since June 20, 2018, Dicot Pharma AB's market cap has increased from 63.22M to 832.49M, an increase of 1,216.87%. That is a compound annual growth rate of 36.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 832.49M | 34.95% |
| Dec 30, 2025 | 616.87M | 43.01% |
| Dec 30, 2024 | 431.35M | 65.92% |
| Dec 29, 2023 | 259.98M | 464.37% |
| Dec 30, 2022 | 46.07M | -35.49% |
| Dec 30, 2021 | 71.41M | 56.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 11.97B |
| Nanexa AB | 2.06B |
| Cereno Scientific AB | 1.24B |
| EQL Pharma AB | 673.28M |
| Cinclus Pharma Holding AB | 593.82M |
| Moberg Pharma AB | 542.58M |
| Enzymatica AB | 429.64M |
| Orexo AB | 228.73M |